Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
3T Biosciences
3T Biosciences is an immunotherapy company focused on developing transformative, next-generation therapies for solid tumors and immune-mediated diseases. Their approach leverages the power of the…
3T Biosciences
3T Biosciences is an immunotherapy company focused on developing transformative, next-generation therapies for solid tumors and immune-mediated diseases. Their approach leverages the power of the…
TL;DR
Focus: TCR-based immunotherapies for solid tumors and immune-mediated diseases
Platform: 3T-TRACE platform for TCR target identification and validation
Founded / HQ: Founded 2017; South San Francisco, CA
Recent funding: $40M Series A (Aug 25, 2022); total funding $52M
Employees: ~28
Company Overview
Problem Domain
Immuno-oncology; discovery and development of TCR-targeted therapies for solid tumors and immune-mediated diseases
Founded
2017
Industry
Biotechnology; Immunotherapy
Funding Track Record
$40,000,000
Series A included participation from Lightspeed Venture Partners
Investor Signal
“Backed by strategic healthcare and life-science investors including Westlake Village BioPartners and participation from Lightspeed Venture Partners; earlier investors include Parker Institute for Cancer Immunotherapy and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,300+
New This Week